Fresh analysis reveals that patients who stop using new weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who end conventional diet and exercise regimens.
Published data in a major medical journal shows that while overweight individuals often shed substantial amounts of their total mass while using the jabs, the mass returns at an average rate of 0.8 kg per month upon discontinuation.
"Users using these drugs need to be informed of the danger of quick rebound weight gain when the therapy is stopped," warns expert Dr. Susan Jebb.
That rate of regain suggests a reversion to original weight in about one and a half years.
Comparing Approaches
The analysis, which looked at dozens of studies involving over 9,000 of participants, contrasted the results of these new drugs with older methods.
Researchers point out that individuals who shed pounds through lifestyle changes alone usually experience a more gradual weight regain—around 100 grams monthly—once they finish.
Explaining the Quick Regain
Nutrition scientists believe the mechanism of the jabs is key to understanding the accelerated weight return.
The injections copy a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 levels several times higher than normal may cause the system to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' means appetite is unsuppressed, making excessive eating a significant risk."
A Chronic Disease?
Health authorities suggest the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, due to the significant potential of relapse, the treatment might need to be life-long.
This perspective is supported by pharmaceutical companies, who state that the findings "underscore the long-term character of excess weight," similar to managing diseases like hypertension.
Patient Experiences
Individuals who have come off the medication explain a intense resurgence of cravings.
"It felt as if a trigger that goes on and you become ravenous," described one woman.
This difficulty is exacerbated if users have not established sustainable lifestyle or habit modifications during therapy.
Growing Interest
Recent estimates show that a significant number of people in the UK have used weight-loss jabs in the past year, with interest being substantial.
- Use is greater among females than men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the drugs through private healthcare rather than the NHS.
Ultimately, researchers emphasize that while the jabs are potent tools for shedding pounds, they are not a permanent fix and long-term success hinges on combined lifestyle management.
